Recruiting studies: Small Cell Lung Cancer Limited Stage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682 Molecular Analysis and Treatment Options of SCLC
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT05945745 Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035 Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454 BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Phase 2 · 33 location(s) · SCRI Development Innovations, LLC · NCT06773910 Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cel
Phase 3 · 2 location(s) · Shandong Cancer Hospital and Institute · NCT04829708 Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03791034 A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage
Phase 2 · 2 location(s) · Henan Cancer Hospital · NCT07559786 MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Phase N/A · 2 location(s) · European Institute of Oncology · NCT05974475 Durvalumab as Consolidation for Patients LS-SCLC
Phase 2 · 2 location(s) · Qian Chu · NCT07055581 Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Phase 1/Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06088771 IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Phase 2 · 30 location(s) · Innate Pharma · NCT05742607 The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523 Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-smal
Phase 2/Phase 3 · 1 location(s) · Kong Fanming · NCT07034326 Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in th
Phase 2 · 1 location(s) · Fudan University · NCT06943235 A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05732974 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harbor
Phase 3 · 199 location(s) · Boehringer Ingelheim · NCT07195695 Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT06256237 To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
NA · 1 location(s) · Anhui Provincial Cancer Hospital · NCT07195084 Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Ca
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06562920 Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT06371482 Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Phase 2 · 20 location(s) · Fundación GECP · NCT07242547 MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
Phase 2 · 4 location(s) · Hirva Mamdani · NCT05903092 The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
Phase N/A · 1 location(s) · yi shen · NCT07596654 Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Phase 2 · 97 location(s) · AstraZeneca · NCT05061550 Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer
Phase 1 · 1 location(s) · St. Joseph's Healthcare Hamilton · NCT02570815 Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
NA · 1 location(s) · University of Rochester · NCT03706027 PD-L1 Antibody (TQB2450) Plus Chemotherapy for Previously Untreated Limited- Stage Small-cell Lung Cancer
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT04539977 Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
Phase N/A · 4 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07309211 Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06542159

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.